Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 8
2006 17
2007 37
2008 52
2009 60
2010 78
2011 112
2012 136
2013 175
2014 206
2015 253
2016 234
2017 254
2018 323
2019 353
2020 471
2021 598
2022 526
Text availability
Article attribute
Article type
Publication date

Search Results

3,483 results
Results by year
Filters applied: . Clear all
Page 1
Rapamycin targets STAT3 and impacts c-Myc to suppress tumor growth.
Sun L, Yan Y, Lv H, Li J, Wang Z, Wang K, Wang L, Li Y, Jiang H, Zhang Y. Sun L, et al. Among authors: lv h. Cell Chem Biol. 2022 Mar 17;29(3):373-385.e6. doi: 10.1016/j.chembiol.2021.10.006. Epub 2021 Oct 26. Cell Chem Biol. 2022. PMID: 34706270
Pyrotinib plus capecitabine for patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases (PERMEATE): a multicentre, single-arm, two-cohort, phase 2 trial.
Yan M, Ouyang Q, Sun T, Niu L, Yang J, Li L, Song Y, Hao C, Chen Z, Orlandi A, Ishii N, Takabe K, Franceschini G, Ricci F, Verschraegen C, Liu Z, Zhang M, Lv H, Liu L, Yang X, Xiao H, Gao Z, Li X, Dong F, Chen X, Qiao J, Zhang G. Yan M, et al. Among authors: lv h. Lancet Oncol. 2022 Mar;23(3):353-361. doi: 10.1016/S1470-2045(21)00716-6. Epub 2022 Jan 31. Lancet Oncol. 2022. PMID: 35085506 Clinical Trial.
Dawning precision treatment for gastric cancer: The latest biomarkers.
Sun K, Lv H, Chen B, Nie C, Zhao J, Wang S, Wang J, Xu W, Chen X. Sun K, et al. Among authors: lv h. J Transl Int Med. 2021 Dec 31;9(4):228-230. doi: 10.2478/jtim-2021-0023. eCollection 2021 Dec 1. J Transl Int Med. 2021. PMID: 35136720 Free PMC article. No abstract available.
3,483 results